IFNAR1 and infection: Our results demonstrated that a single dose of the MVA-ZIKV vaccine administered intramuscularly (IM) in the early 2-days before the highly pathogenic ZIKV challenge fully protected IFNAR-/- non-pregnant and pregnant mice against lethal infection and prevented in-utero transmission of ZIKV.